Tang Capital Management’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.13M Sell
451,114
-414,055
-48% -$5.82M 0.21% 40
2025
Q4
$13.8M Sell
865,169
-32,447
-4% -$946K 0.68% 33
2025
Q3
$41.8M Hold
897,616
1.61% 15
2025
Q2
$26.3M Buy
897,616
+130,676
+17% +$3.55M 1.33% 22
2025
Q1
$19.7M Hold
766,940
1.09% 25
2024
Q4
$22.1M Hold
766,940
1.47% 17
2024
Q3
$18.2M Buy
766,940
+19,324
+3% +$429K 1.3% 21
2024
Q2
$12.9M Buy
747,616
+200,000
+37% +$3.49M 1.32% 25
2024
Q1
$12.2M Buy
547,616
+191,647
+54% +$3.98M 1.27% 25
2023
Q4
$6.53M Buy
355,969
+67,880
+24% +$1.12M 0.6% 40
2023
Q3
$5M Sell
288,089
-9,857
-3% -$171K 0.71% 43
2023
Q2
$5.42M Buy
297,946
+8,165
+3% +$163K 0.8% 36
2023
Q1
$4.97M Buy
289,781
+132,638
+84% +$2.15M 0.74% 42
2022
Q4
$3.65M Hold
157,143
0.53% 46
2022
Q3
$3.49M Hold
157,143
0.43% 51
2022
Q2
$3.02M Buy
+157,143
New +$3.5M 0.46% 42

Other funds holding LENZ